NEWS ITEMS

thromboDx BV awarded prestigous NGI Preseed Grant

Posted on

Dr. Thomas Wurdinger from thromboDx BV was awarded a prestigous Preseed grant: Diagnosing cancer from thrombocytes for personalized applications. Summary: The development of diagnostics platforms that provide biomarkers which are highly predictive for diagnosing, monitoring and stratifying cancer patients are key instruments in personalized medicine. Thrombocytes (blood platelets) are a novel source of high-quality tumor-derived…

Read

Science: Platelets take up tumor-derived RNA

Posted on

The scientific journal Blood publishes the landmark paper describing the principle of platelet-powered diagnostics. Dr. Jonas Nilsson and colleagues demonstrate that platelets can effciently acquire and protect circulating tumor-derived RNA. Since platelet isolation is routine in most hospitals this finding provides the basis of a new diagnostics platform that is easily adaptable to standard care.  In this publication…

Read